R Street Institute

In the News

Could a patent get in between you and a Covid-19 test? Yes

by Charles Duan
May 28, 2020
Print
issues: Health Tech, Patent Policy, Technology and Innovation
originally published in The Guardian
From The Guardian:

In 2001, the United States faced a credible threat of an anthrax outbreak, yet Bayer refused to license its patents on ciprofloxacin (Cipro), the most effective antibiotic treatment for anthrax, to competitors, even as Bayer itself struggled to supply the nation’s antibiotic stockpile.

Featured Publications